pcNewsWire – Liberty Leaf Holdings Ltd. (CSE: LIB; OTCQB: LIBFF; FSE: HN3P) has closed a non-brokered private placement of 2,270,000 units at $0.125 per unit for gross proceeds of $283,750.
Proceeds will be used on continued due diligence focusing on revenue-generating cannabis sector businesses, the ongoing development of its existing ventures and for general working capital purposes.
Liberty Leaf Holdings Closes Financing
Vancouver, BC – May 24, 2017: Liberty Leaf Holdings Ltd. (CSE: LIB, OTCQB: LIBFF and FSE: HN3P) (the “Company” or “Liberty Leaf) is pleased to announce that it has closed a nonbrokered
private placement financing (the “Private Placement”) for total gross proceeds of $283,750.
The Company has allotted and issued 2,270,000 units (the “Units”) at a price of $0.125 per Unit. Each Unit is comprised of one common share and one transferable share purchase warrant, with each warrant entitling the holder to purchase one additional common share of the Company for a period of up to twenty-four months at a price of $0.20.
In addition, the Company has paid finder’s fees of a total of $18,125 and issued an aggregate 145,000 finder’s warrants (the “Finders Warrants”). Each Finders Warrant is exercisable into one common share for a period of up to twenty-four months at a price of $0.20.
The Company will use the proceeds of the Private Placement on continued due diligence focusing on revenue-generating cannabis sector businesses, the ongoing development of its existing ventures and for general working capital purposes. All securities issued under the Private Placement are subject to a four-month and one-day hold period expiring on September 25, 2017.
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a new Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis sector businesses, including cultivation, value
added CBD/THC products, biotech research, and supply chain products within this dynamic and fast growing sector.
Liberty Leaf also owns 100% of North Road Ventures, a late-stage applicant under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
For further info on the Company please visit www.libleaf.com or email email@example.com.
On Behalf of the Board
Will Rascan, President & CEO
Liberty Leaf Holdings Ltd.